HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A STING antagonist modulating the interaction with STIM1 blocks ER-to-Golgi trafficking and inhibits lupus pathology.

AbstractBACKGROUND:
Nucleic acids are potent stimulators of type I interferon (IFN-I) and antiviral defense, but may also promote pathological inflammation. A range of diseases are characterized by elevated IFN-I, including systemic lupus erythematosus (lupus). The DNA-activated cGAS-STING pathway is a major IFN-I-inducing pathway, and activation of signaling is dependent on trafficking of STING from the ER to the Golgi.
METHODS:
Here we used cell culture systems, a mouse lupus model, and material from lupus patients, to explore the mode of action of a STING antagonistic peptide, and its ability to modulate disease processes.
FINDINGS:
We report that the peptide ISD017 selectively inhibits all known down-stream activities of STING, including IFN-I, inflammatory cytokines, autophagy, and apoptosis. ISD017 blocks the essential trafficking of STING from the ER to Golgi through a mechanism dependent on the STING ER retention factor STIM1. Importantly, ISD017 blocks STING activity in vivo and ameliorates disease development in a mouse model for lupus. Finally, ISD017 treatment blocks pathological cytokine responses in cells from lupus patients with elevated IFN-I levels.
INTERPRETATION:
These data hold promise for beneficial use of STING-targeting therapy in lupus.
FUNDING:
The Novo Nordisk Foundation, The European Research Council, The Lundbeck Foundation, European Union under the Horizon 2020 Research, Deutsche Forschungsgemeinschaft, Chulalongkorn University.
AuthorsThaneas Prabakaran, Anne Troldborg, Sarinya Kumpunya, Isara Alee, Emilija Marinković, Samuel J Windross, Ramya Nandakumar, Ryo Narita, Bao-Cun Zhang, Mikkel Carstensen, Pichpisith Vejvisithsakul, Mikkel H S Marqvorsen, Marie B Iversen, Christian K Holm, Lars J Østergaard, Finn Skou Pedersen, Trairak Pisitkun, Rayk Behrendt, Prapaporn Pisitkun, Søren R Paludan
JournalEBioMedicine (EBioMedicine) Vol. 66 Pg. 103314 (Apr 2021) ISSN: 2352-3964 [Electronic] Netherlands
PMID33813142 (Publication Type: Journal Article)
CopyrightCopyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.
Chemical References
  • Membrane Proteins
  • Neoplasm Proteins
  • STIM1 protein, human
  • STING1 protein, human
  • Stromal Interaction Molecule 1
Topics
  • Animals
  • Cell Line
  • Disease Models, Animal
  • Disease Susceptibility
  • Endoplasmic Reticulum (metabolism)
  • Extracellular Vesicles (metabolism)
  • Gene Expression
  • Golgi Apparatus (metabolism)
  • Humans
  • Lupus Erythematosus, Systemic (drug therapy, etiology, metabolism, pathology)
  • Membrane Proteins (antagonists & inhibitors)
  • Mice
  • Mice, Knockout
  • Neoplasm Proteins (metabolism)
  • Protein Transport (drug effects)
  • Stromal Interaction Molecule 1 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: